Back to Search
Start Over
Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage.
- Source :
-
Dermatologic therapy [Dermatol Ther] 2019 May; Vol. 32 (3), pp. e12841. Date of Electronic Publication: 2019 Feb 10. - Publication Year :
- 2019
-
Abstract
- Hidradenitis suppurativa is a chronic skin disease with an intense inflammatory activation. It typically affects the intertriginous areas with cysts, fistulae, and scarring extremely painful. Patients suffer from severe psychological impact. HS still results in a high unmet medical need with several underdiagnosed cases, probably due to the incomplete knowledge of the pathogenesis of HS. The use of botulinum toxin a has recently been proposed as an effective therapy for HS.<br /> (© 2019 Wiley Periodicals, Inc.)
- Subjects :
- Female
Hidradenitis Suppurativa diagnosis
Hidradenitis Suppurativa physiopathology
Humans
Male
Middle Aged
Pain drug therapy
Pain etiology
Treatment Outcome
Young Adult
Botulinum Toxins, Type A administration & dosage
Hidradenitis Suppurativa drug therapy
Neuromuscular Agents administration & dosage
Subjects
Details
- Language :
- English
- ISSN :
- 1529-8019
- Volume :
- 32
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Dermatologic therapy
- Publication Type :
- Academic Journal
- Accession number :
- 30693648
- Full Text :
- https://doi.org/10.1111/dth.12841